GLOBAL HEALTH Latest Share Price (MEDANTA)
TODAY IN ONE LINE
MEDANTA slipped 0.8% on light volume, in line with Nifty's -0.3% move, supported by recent strong earnings.
With a market cap of ₹38,774 Cr., it trades at a P/E of 69.70. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
GLOBAL HEALTH flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 42.0% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 20.9% and Profit up 14.5%
- ●Healthy Operating MarginsOPM is structurally strong at 18.6%
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.17x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Expensive ValuationTrading at a high P/E ratio of 64.5x
- ●Rising Receivables vs SalesReceivables grew 31.3% outpacing sales growth of 12.7%
Latest GLOBAL HEALTH News
What changed recently?
Recent events, corporate actions, and announcements.
GLOBAL HEALTH valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for GLOBAL HEALTH, framed against the sector median so the premium or discount is obvious at a glance.
GLOBAL HEALTH trades at a P/E of 69.70× and P/B of 9.78×, against the Healthcare sector median P/E of 46.02×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
GLOBAL HEALTH technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for GLOBAL HEALTH — derived from the latest tape, not yesterday's close.
GLOBAL HEALTH last traded at ₹1,447.2 with an intraday range of ₹1,432.3–₹1,459.7 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1447.20| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1515.30 | +68.10 | +4.71% |
| R3 | 1487.90 | +40.70 | +2.81% |
| R2 | 1473.80 | +26.60 | +1.84% |
| R1 | 1460.50 | +13.30 | +0.92% |
| PIVOT | 1446.40 | -0.80 | -0.06% |
| CURRENT | 1447.20 | — | — |
| S1 | 1433.10 | -14.10 | -0.97% |
| S2 | 1419.00 | -28.20 | -1.95% |
| S3 | 1405.70 | -41.50 | -2.87% |
| S4 | 1378.30 | -68.90 | -4.76% |
MEDANTA is trading Above CPR, indicating Bullishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹1432.3–₹1450.1
Trading Inside opening range
GLOBAL HEALTH financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for GLOBAL HEALTH — consolidated or standalone — with margins, YoY growth and key ratios inline.
GLOBAL HEALTH reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹38,774 Cr. and reported EPS of ₹5.90.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 3,692 | 4,410 ▲ 19.4% |
| Sales Growth YoY %Derived | 12.74% | 19.44% |
| Other Income | 79 | 99 ▲ 24.6% |
| Total Income | 3,771 | 4,509 ▲ 19.6% |
| 880 | 997 ▲ 13.3% | |
| Gross ProfitDerived | 2,813 | 3,413 ▲ 21.4% |
| Gross Margin %Derived | 76.18% | 77.40% |
| 1,936 | 2,494 ▲ 28.9% | |
| EBITDA (Operating Profit)Derived | 877 | 919 ▲ 4.8% |
| OPM %Derived | 23.75% | 20.84% |
| 209 | 301 ▲ 43.8% | |
| Profit Before Tax (PBT) | 647 | 715 ▲ 10.5% |
| 166 | 161 ▼ 3.0% | |
| Effective Tax %Derived | 25.64% | 22.51% |
| Total Profit for Period | 481 | 554 ▲ 15.1% |
| Less: Non-controlling Interests | -0 | -2 ▼ 1910.1% |
| Net Profit (Owner's PAT)Derived | 481 | 556 ▲ 15.6% |
| Net Profit Margin %Derived | 13.04% | 12.62% |
| PAT Growth YoY %Derived | 0.68% | 15.58% |
| Earnings Per Share (EPS ₹) | 17.92 | 20.70 ▲ 15.5% |
| Diluted Shares Outstanding (Cr) | 27 | 27 ▲ 0.1% |
| Other Comprehensive Income (Net of Tax) | -1 | 4 ▲ 644.0% |
| Total Expenses (incl. D&A & Interest) | 3,124 | 3,794 ▲ 21.4% |
| Material Cost % of RevenueDerived | 21.39% | 20.00% |
| Employee Cost % of RevenueDerived | 22.33% | 24.85% |
| Other Cost % of RevenueDerived | 30.09% | 31.70% |
| Interest Coverage (x)Derived | 10.47x | 8.80x |
| Period | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|
| Revenue from Operations | 2,694 | 3,275 ▲ 21.6% | 3,692 ▲ 12.7% | 4,410 ▲ 19.4% | |
| Sales Growth YoY %Derived | — | 21.56% | 12.74% | 19.44% | |
| Other Income | 65 | 75 ▲ 15.0% | 79 ▲ 5.9% | 99 ▲ 24.6% | |
| Total Income | 2,759 | 3,350 ▲ 21.4% | 3,771 ▲ 12.6% | 4,509 ▲ 19.6% | |
625 | 759 ▲ 21.4% | 880 ▲ 15.8% | 997 ▲ 13.3% | ||
| Gross ProfitDerived | 2,069 | 2,516 ▲ 21.6% | 2,813 ▲ 11.8% | 3,413 ▲ 21.4% | |
| Gross Margin %Derived | 76.79% | 76.81% | 76.18% | 77.40% | |
1,457 | 1,717 ▲ 17.8% | 1,936 ▲ 12.8% | 2,494 ▲ 28.9% | ||
| EBITDA (Operating Profit)Derived | 612 | 799 ▲ 30.5% | 877 ▲ 9.8% | 919 ▲ 4.8% | |
| OPM %Derived | 22.72% | 24.40% | 23.75% | 20.84% | |
228 | 247 ▲ 8.3% | 209 ▼ 15.2% | 301 ▲ 43.8% | ||
| Profit Before Tax (PBT) | 449 | 627 ▲ 39.6% | 647 ▲ 3.2% | 715 ▲ 10.5% | |
123 | 149 ▲ 21.0% | 166 ▲ 11.3% | 161 ▼ 3.0% | ||
| Effective Tax %Derived | 27.42% | 23.77% | 25.64% | 22.51% | |
| Total Profit for Period | 326 | 478 ▲ 46.6% | 481 ▲ 0.7% | 554 ▲ 15.1% | |
| Less: Non-controlling Interests | — | -0 | -0 ▲ 11.2% | -2 ▼ 1910.1% | |
| Net Profit (Owner's PAT)Derived | 326 | 478 ▲ 46.6% | 481 ▲ 0.7% | 556 ▲ 15.6% | |
| Net Profit Margin %Derived | 12.10% | 14.60% | 13.04% | 12.62% | |
| PAT Growth YoY %Derived | — | 46.65% | 0.68% | 15.58% | |
| Earnings Per Share (EPS ₹) | 12.16 | 17.81 ▲ 46.5% | 17.92 ▲ 0.6% | 20.70 ▲ 15.5% | |
| Diluted Shares Outstanding (Cr) | 27 | 27 ▲ 0.1% | 27 ▲ 0.0% | 27 ▲ 0.1% | |
| Other Comprehensive Income (Net of Tax) | 1 | -1 ▼ 166.0% | -1 ▲ 28.6% | 4 ▲ 644.0% | |
| Total Expenses (incl. D&A & Interest) | 2,310 | 2,723 ▲ 17.9% | 3,124 ▲ 14.7% | 3,794 ▲ 21.4% | |
| Material Cost % of RevenueDerived | 21.20% | 21.00% | 21.39% | 20.00% | |
| Employee Cost % of RevenueDerived | 23.54% | 22.44% | 22.33% | 24.85% | |
| Other Cost % of RevenueDerived | 30.52% | 29.98% | 30.09% | 31.70% | |
| Interest Coverage (x)Derived | 5.93x | 8.47x | 10.47x | 8.80x |
GLOBAL HEALTH segment analysis : revenue and profit mix.
Disclosed business segments at GLOBAL HEALTH with their share of revenue and profit, switchable between consolidated and standalone reporting.
GLOBAL HEALTH discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for GLOBAL HEALTH.
Our AI distills the core fundamental drivers supporting GLOBAL HEALTH, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
GLOBAL HEALTH's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Valuation risk. a P/E above 91 (~2.0× the sector multiple of 46.0) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
GLOBAL HEALTH peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — GLOBAL HEALTH is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
GLOBAL HEALTH chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for GLOBAL HEALTH — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
GLOBAL HEALTH delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for GLOBAL HEALTH over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in GLOBAL HEALTH stood at 41.4% of traded volume, against a 20-day average of 54.0%.
GLOBAL HEALTH announcements: results, concalls, ratings, M&A.
Filings GLOBAL HEALTH sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
GLOBAL HEALTH files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 213 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Global Health Limited has informed the Exchange about Schedule of meet.
Analysts/Institutional Investor Meet/Con. Call Updates
Global Health Limited has informed the Exchange about Schedule of meet
Analysts/Institutional Investor Meet/Con. Call Updates
Global Health Limited has informed the Exchange about Schedule of meet
Analysts/Institutional Investor Meet/Con. Call Updates
Global Health Limited has informed the Exchange about Schedule of meet
Analysts/Institutional Investor Meet/Con. Call Updates
Global Health Limited has informed the Exchange about Schedule of meet
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Analysts/Institutional Investor Meet/Con. Call Updates
GLOBAL HEALTH dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue GLOBAL HEALTH has declared, sequenced by announce and record date.
GLOBAL HEALTH corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About GLOBAL HEALTH: business, sector, key facts.
What GLOBAL HEALTH does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
GLOBAL HEALTH operates in the Hospital industry under the Healthcare sector, listed as NSE: MEDANTA, BSE: 543654.
Medanta, operating under Global Health Limited, is a prominent healthcare provider in India offering a comprehensive range of medical services. Their business model centers around a network of hospitals under the Medanta brand, delivering advanced medical treatments across numerous specialties. This wide-ranging approach allows them to cater to a broad spectrum of patient needs, from routine check-ups to complex, life-saving procedures.
The company's services span a vast array of medical disciplines. These include highly specialized areas such as cardiac and cancer care, neurosciences, liver and lung transplants, and bone marrow transplants. Alongside these advanced treatments, Medanta also provides a comprehensive suite of general medical services, encompassing digestive and hepatobiliary sciences, musculoskeletal disorders and orthopedics, renal care, and a wide range of surgical specialities including plastic, aesthetic and reconstructive surgery, ENT, and chest surgery. Furthermore, they offer substantial care for women's health, covering gynecology, obstetrics, and pediatric care.
Beyond direct patient care, Medanta's business extends to supporting services that enhance the patient experience and overall healthcare access. These ancillary services include advanced diagnostic and laboratory testing, convenient homecare and elder care options, and the utilization of telemedicine to expand reach. They also provide critical support services like a blood bank, e-ICU services, and air ambulance services for emergency situations. In addition, Medanta offers health plans to facilitate access to their services and operates in-house pharmacies for patient convenience.
In summary, Medanta's business model integrates advanced medical treatments with comprehensive support services to establish a robust and multifaceted healthcare system. Their focus on a wide range of specializations, coupled with their commitment to ancillary services, positions Medanta as a major player in the Indian healthcare market, providing a holistic approach to patient care and accessibility.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- DR AGARWALS HEALTH CARE L (AGARWALEYE) Share PricePeer
- APOLLO HOSPITALS ENTER L (APOLLOHOSP) Share PricePeer
- ARTEMIS MED SERVICE (ARTEMISMED) Share PricePeer
- ASTER DM QUALITY CARE (ASTERDM) Share PricePeer
- FORTIS HEALTHCARE (FORTIS) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about GLOBAL HEALTH (MEDANTA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of GLOBAL HEALTH (MEDANTA)?
The current share price of GLOBAL HEALTH (MEDANTA) is ₹1,447.20. Today, the stock has declined by ₹12.40 (0.85%), trading in a range of ₹1,432.30 to ₹1,459.70. The stock opened at ₹1,450.10 with a trading volume of 74,678 shares.
02Is GLOBAL HEALTH stock a good investment for long-term?
GLOBAL HEALTH can be considered for long-term investment based on several factors. The company has a market capitalization of ₹38,774 Cr., P/E ratio of 69.7, ROE of 12.37%, and ROCE of 11.4%. The dividend yield stands at 0.03%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of GLOBAL HEALTH stock?
The 52-week high price of GLOBAL HEALTH (MEDANTA) is ₹1,544.00, while the 52-week low is ₹956.00. Currently trading at ₹1,447.20, the stock is 51.38% above its 52-week low and 6.27% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy GLOBAL HEALTH stock at the current price?
Whether to buy GLOBAL HEALTH stock at ₹1,447.20 depends on multiple factors. The stock is currently trading with a P/E ratio of 69.7 and P/B ratio of 9.78. Today's performance shows a loss of 0.85%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of GLOBAL HEALTH and when is the next dividend?
GLOBAL HEALTH offers a dividend yield of 0.03%, which means for every ₹100 invested at the current price of ₹1,447.20, you can expect to receive approximately ₹0.03 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of GLOBAL HEALTH?
GLOBAL HEALTH's key financial metrics include: P/E Ratio: 69.7, P/B Ratio: 9.78, ROE: 12.37%, ROCE: 11.4%, Dividend Yield: 0.03%, EPS: ₹5.90, Book Value: ₹148.18, and Debt-to-Equity: 0.17. The company's market cap stands at ₹38,774 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is GLOBAL HEALTH stock performing today in the market?
GLOBAL HEALTH stock opened at ₹1,450.10 and is currently trading at ₹1,447.20, showing a decline of ₹12.40 (0.85%). The intraday high is ₹1,459.70 and low is ₹1,432.30. The trading volume stands at 74,678 shares, indicating moderate market participation today.
08What is the P/E ratio of GLOBAL HEALTH and what does it indicate?
GLOBAL HEALTH has a Price-to-Earnings (P/E) ratio of 69.7, which means investors are willing to pay 69.70 for every ₹1 of earnings. With an EPS of ₹5.90, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about GLOBAL HEALTH (MEDANTA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.